Table 1.
Age (year; mean ± SD) | 47.57 ± 10.31 |
Gender [n (%)] | |
Male | 270 (80.60) |
Female | 65 (19.40) |
BMI (kg/m2) | 24.86 ± 3.79 |
Preoperative factors [n (%)] | |
Hypertension/CHD | 181 (54.03) |
Congestive heart failure | 101 (30.15) |
A left ventricular ejection fraction of <35% | 27 (8.06) |
Marfan syndrome | 11 (3.28) |
CKD | 23 (6.87) |
COPD | 17 (5.07) |
Diabetes | 10 (2.99) |
Chronic liver disease | 15 (4.48) |
Previous cardiac surgery | 17 (5.07) |
Aortic regurgitation | 134 (40.00) |
Hypercholesterolemia | 20 (5.97) |
Hypertriglyceridemia | 82 (24.48) |
Intraoperative factors | |
MHCA [n (%)] | 248 (74.03) |
DHCA [n (%)] | 87 (25.97) |
CPB duration (min) | 257.20 ± 57.90 |
Red blood cell transfusion (units) | 3.04 ± 2.69 |
Lowest HGB intraoperative (g/L) | 75.04 ± 10.77 |
Complication [n (%)] | |
SIRS | 109 (32.54) |
ARDS | 47 (14.03) |
Hepatic failure | 41 (12.24) |
Hypoproteinemia | 72 (21.49) |
Lactic acidosis | 62 (18.51) |
Laboratory | |
Baseline Scr (μmol/L) | 90.18 ± 54.46 |
BUN (mmol/L) | 7.46 ± 4.23 |
UA (umol/L) | 368.51 ± 127.07 |
Cys-C (mg/L) | 1.98 ± 1.53 |
HGB (g/L) | 128.32 ± 19.96 |
Low hematocrit levels [<24%; n %)] | 61 (18.21) |
PLT (109/L) | 166.85 ± 95.89 |
WBC (109/L) | 11.42 ± 7.18 |
N (%) | 79.65 ± 10.92 |
Surgical treatment | |
Hemiarch reconstruction | 125 (37.3) |
Total arch replacement | 210 (62.7) |
LOS in hospital (days) | 22.54 ± 9.90 |
CRRT [n (%)] | 41 (12.24) |
Mortality [n (%)] | 60 (17.91) |
Continuous variables with normal distribution were reported as the mean ± standard deviation (SD); categorical variables were reported as number (percentage).
SD, standard deviation; BMI, body mass index; CHD, coronary heart disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; MHCA, moderate hypothermic circulatory arrest; DHCA, deep hypothermic circulatory arrest; CPB, cardiopulmonary bypass; HGB, hemoglobin; SIRS, systemic inflammatory response syndrome; ARDS, acute respiratory distress syndrome; Scr, serum creatinine; BUN, blood urea nitrogen; UA, uric acid; Cys-C, cystatin C; PLT, platelet; WBC, white blood cell; N, neutrocyte; LOS, length of stay; CRRT, continuous renal replacement therapy.